Ftse Mib
34.339,32
0,55%
DAX
18.686,60
1,07%
S&P 500
5.214,08
0,51%
NASDAQ
16.346,26
0,27%
Bitcoin
62.989,52
-0,09%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Maxcyte Inc (MXCN) Maxcyte Inc (MXCN) Notizie

Maxcyte Inc

MXCN
680,00
0,00 (0,00%)
09 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: GBX

Ultime notizie

Data Ora Fonte Titolo
07/5/202422:05GLOBEMaxCyte Reports First Quarter 2024 Financial Results and..
10/4/202414:05GLOBEMaxCyte to Report First Quarter 2024 Financial Results on..
02/4/202414:05GLOBEMaxCyte Signs Strategic Platform License with Be Biopharma..
12/3/202421:05UKREGMaxCyte Reports Fourth Quarter and Full Year 2023 Financial..
04/3/202422:05UKREGMaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023..
09/2/202414:05UKREGMaxCyte to Report Fourth Quarter and Full Year 2023..
30/1/202414:05UKREGMaxCyte and Wugen Sign Strategic Platform License to..
23/1/202414:05GLOBEMaxCyte Signs Strategic Platform License with Imugene to..
08/1/202422:05GLOBEMaxCyte Announces Preliminary Unaudited Fourth Quarter and..
03/1/202414:05GLOBEMaxCyte and Lion TCR form Partnership to Support Global..
02/1/202408:00GLOBEMaxCyte Confirms Appointment of Maher Masoud as President,..
11/12/202322:05GLOBEMaxCyte Announces CEO Transition and Updates Revenue..
16/11/202314:05GLOBEMaxCyte Joins the Alliance for mRNA Medicines (AMM) as a..
08/11/202322:05GLOBEMaxCyte Reports Third Quarter 2023 Financial Results and..
06/11/202322:05GLOBEMaxCyte to Participate in Two Upcoming Investor Conferences
04/10/202322:05GLOBEMaxCyte Announces Preliminary Third Quarter 2023 Revenue and..
06/9/202314:05GLOBEMaxCyte Appoints Ali Soleymannezhad as Executive Vice..
05/9/202314:05GLOBEMaxCyte to Participate in Baird Global Healthcare Conference
09/8/202322:05GLOBEMaxCyte Reports Second Quarter and Half-Year 2023 Financial..
01/8/202314:05GLOBEMaxCyte Signs Strategic Platform License with Prime Medicine..
13/7/202314:05GLOBEMaxCyte to Report Second Quarter 2023 Financial Results on..
10/7/202314:05GLOBEMaxCyte and Vittoria Biotherapeutics Sign Strategic Platform..
06/7/202314:05GLOBEMaxCyte Signs Strategic Platform License with Lyell..
01/6/202322:05GLOBEMaxCyte to Participate in Upcoming Investor Conferences
Apertura: Min: Max:
Chiusura: 680,00

La tua Cronologia

LSE
MXCN
Maxcyte
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network